BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16821707)

  • 1. New antimycobacterial 2,3-dihydro-1-alkylindole-2-thiones.
    Waisser K; Heinisch L; Slosárek M; Janota J
    Folia Microbiol (Praha); 2006; 51(1):25-6. PubMed ID: 16821707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antimycobacterial S-alkylisothiosemicarbazones.
    Waisser K; Heinisch L; Slosárek M; Janota J
    Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
    Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
    Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
    Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.
    Disratthakit A; Doi N
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2684-6. PubMed ID: 20368403
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible?
    Ho II; Chan CY; Cheng AF
    Antimicrob Agents Chemother; 2000 Jan; 44(1):39-42. PubMed ID: 10602720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active antimycobacterial derivatives of benzoxazine.
    Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
    Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis.
    Ashtekar DR; Costa-Periera R; Shrinivasan T; Iyyer R; Vishvanathan N; Rittel W
    Diagn Microbiol Infect Dis; 1991; 14(6):465-71. PubMed ID: 1802533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids.
    Waisser K; Dolezal R; Palát K; Cizmárik J; Kaustová J
    Folia Microbiol (Praha); 2006; 51(1):21-4. PubMed ID: 16821706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime.
    Abate G; Hoffner SE
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):119-22. PubMed ID: 9294701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
    Barrett MS; Jones RN; Erwin ME; Koontz FP
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2):169-71. PubMed ID: 1315233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
    Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases.
    Yamori S; Ichiyama S; Shimokata K; Tsukamura M
    Microbiol Immunol; 1992; 36(4):361-8. PubMed ID: 1406364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution and drug resistance of nontuberculous
    Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
    [No Abstract]   [Full Text] [Related]  

  • 19. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
    Nikonenko BV; Kornienko A; Majorov K; Ivanov P; Kondratieva T; Korotetskaya M; Apt AS; Salina E; Velezheva V
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6422-4. PubMed ID: 27503657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana.
    Otchere ID; Asante-Poku A; Osei-Wusu S; Aboagye SY; Yeboah-Manu D
    Int J Mycobacteriol; 2017; 6(1):70-75. PubMed ID: 28317808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.